system for receiving and delivery the client ’s assets between the intermediary and such third party, and for monitoring the consequence thereof. In this regard, while awaited delivery of the asset or

% Other current assets 82.73 80.35 (2.38) (2.88%) Advance payment for purchased program rights 655.21 357.69 (297.52) (45.41%) Program rights 1,181.01 1,449.30 268.29 22.72% Other non-current assets 75.90

construction of Kasemrad Hospital Prachinburi and Kasemrad International Hospital Vientiane, and land purchased by the subsidiary to support the hospital capacity expansion. The Company had total liabilities of

percent for three months period and increased by 5.6 percent for the nine months period respectively. Most of the higher expenses are staff expenses that are normally raised and the increased delivery costs

customers, which entered into short-term contract with specific quantities and delivery term (Made to Order). This helps the Company to efficiently control inventories aging and procurement that prevent risk

during the end of the year 2020, the Company has issued a sales tax invoice from the receipt of payment and delivery of the goods. Therefore, the Input tax and the Input tax not yet due decrease. Other non

slightly increased from Q3–2023 and Q4–2022 because the company has accelerated the project to complete delivery it at the end of 2023. Cost of Sale and Service Cost of Sale and Service in Q4–2023 decreased

) Consolidated The Company only ( 20..) ( 20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under reverse repurchase agreement 4. Investments

20.. Assets (Unit:Baht) Consolidated The Company only (20..) (20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under reverse

) ………………………………….20.. and 20.. Assets (Unit:Baht) Consolidated The Company only (20..) (20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under